Assessing the impact of the physical properties of industrially produced carbon nanotubes on their interaction with human primary macrophages in vitro

BioNanoMaterials

Volumn 14, Issue 3-4, 2013, Pages 239-248

  Frey, Sabine ^a   Endes, Carola ^a   Hirsch, Vera ^a   Kuhn, Dagmar A ^a   Johnston, Blair D ^a   Wick, Peter ^b   Petri Fink, Alke ^a   Rothen Rutishauser, Barbara ^a  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

^b SWISS FEDERAL LABORATORIES FOR MATERIALS SCIENCE AND TECHNOLOGY   (Switzerland)

Author keywords

carbon nanotubes (CNTs); industrial CNTs; monocyte derived macrophages (MDM); nanofiber cell interaction; oxidative stress; pro inflammatory response

Indexed keywords

EID: 85017190848     PISSN: 21930651     EISSN: 2193066X     Source Type: Journal    
DOI: 10.1515/bnm-2013-0013     Document Type: Article

References (51)

1. Piccinno F, Gottschalk F, Seeger S, Nowack B. Industrial production quantities and uses of ten engineered nanomaterials in Europe and the world. J Nanopart Res 2012;14:1109.
2. Kostarelos K, Bianco A, Prato M. Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat Nanotech 2009;4:627–633.
3. Robertson J. Realistic applications of CNTs. Mater Today 2004;7:46–52.
4. NIOSH. General safe practices for working with engineered nanomaterials in research laboratories. Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 2012–147, 2012.
5. Maynard AD, Baron PA, Foley M, Shvedova AA, Kisin ER, Castranova V. Exposure to carbon nanotube material: aerosol release during the handling of unrefined singlewalled carbon nanotube material. J Tox Environ Health Part A 2004;67:87–107.
6. Mueller L, Gasser M, Raemy DO, Herzog F, Brandenberger C, Schmid O, et al. Realistic exposure methods for investigating the interaction of nanoparticles with the lung at the air-liquid interface in vitro. InSci J (Nanotech) 2011;1:30–64.
7. Oberdorster G, Stone V, Donaldson K. Toxicology of nanoparticles: a historical perspective. Nanotox 2007;1:2–25.
8. Rothen-Rutishauser B, Blank F, Muehlfeld C, Gehr P. In vitro models of the human epithelial airway barrier to study the toxic potential of particulate matter. Exp Opin Drug Metab Toxicol 2008;4:1075–1089.
9. Van Berlo D, Clift MJ, Albrecht C, Schins RP. Carbon nanotubes: an insight into the mechanisms of their potential genotoxicity. Swiss Med Wkly 2012;142:w13698.
10. Clift MJ, Foster EJ, Vanhecke D, Studer D, Wick P, Gehr P, et al. Investigating the interaction of cellulose nanofibers derived from cotton with a sophisticated 3D human lung cell coculture. Biomacromol 2011;12:3666–3673.
11. Timbrell J. Principles of biochemical toxicology. CRC Press, UK: Taylor and Francis, 1999.
12. Wick P, Clift MJ, Rosslein M, Rothen-Rutishauser B. A brief summary of the past 20 years of carbon nanotubes in science: a health and safety perspective. Chemsuschem 2011;4: 905–911.
13. Johnston HJ, Hutchison GR, Christensen FM, Peters S, Hankin S, Aschberger K, et al. A critical review of the biological mechanisms underlying the in vivo and in vitro toxicity of carbon nanotubes: the contribution of physico-chemical characteristics. Nanotox 2010;4:207–246.
14. NIOSH Current Intelligence Bulletin 65. Occupational exposure to carbon nanotubes and nanofibres. Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 2013–145, 2013.
15. Lam CW, James JT, McCluskey R, Hunter RL. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 2004;77:126–134.
16. Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, et al. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 2005;289: L698–708.
17. Muller J, Huaux F, Moreau N, Misson P, Heilier JF, Delos M, et al. Respiratory toxicity of multiwall carbon nanotubes. Toxicol Appl Pharmacol 2005;207:221–231.
18. Shvedova AA, Kisin E, Murray AR, Johnson VJ, Gorelik O, Arepalli S, et al. Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. Am J Physiol Lung Cell Mol Physiol 2008;295:L552–65.
19. Ma-Hock L, Treumann S, Strauss V, Brill S, Luizi F, Mertler M, et al. Inhalation toxicity of multi-wall carbon nanotubes in rats exposed for 3 months. Toxicol Sci 2009;112:468–481.
20. Pauluhn J. Subchronic 13-week inhalation exposure of rats to multiwalled carbon nanotubes: toxic effects are determined by density of agglomerate structures, not fibrillar structures. Toxicol Sci 2010;113:226–242.
21. Porter DW, Hubbs AF, Mercer RR, Wu N, Wolfarth MG, Sriram K, et al. Mouse pulmonary dose-and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicol 2010;269:136–147.
22. Mercer RR, Hubbs AF, Scabilloni JF, Wang L, Battelli LA, Friend S, et al. Pulmonary fibrotic response to aspiration of multiwalled carbon nanotubes. Part Fibre Toxicol 2011;8:21.
23. Stanton MF, Layard M, Tegeris A, Miller E, May M, Kent E. Carcinogenicity of fibrous glass: pleural response in the rat in relation to fiber dimension. J Nat Can Inst 1977;58:587–603.
24. Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WA, Seaton A, et al. Carbon nanotubes introduced into the abdominal cavity ofmice show asbestoslike pathogenicity in a pilot study. Nat Nanotech 2008;3:423–428.
25. Donaldson K, Murphy FA, Duffin R, Poland CA. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre tetention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol 2010;7:5.
26. Murphy FA, Poland CA, Duffin R, Al-Jamal KT, Ali-Boucetta H, Nunes A, et al. Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. Am J Path 2011;178:6.
27. Murphy FA, Schinwald A, Poland CA, Donaldson K. The mechanism of pleural inflammation by long carbon nanotubes: interaction of long fibers with macrophages stimulates them to amplify proinflammatory responses in mesothelial cells. Part Fibre Toxicol 2012;9:8.
28. Fenoglio I, Greco G, Tomatis M, Muller J, Raymundo-Pinìfero E, Beguin Fo, et al. Structural defects play a major role in the acute lung toxicity of multiwall carbon nanotubes: physicochemical aspects. Chem Res Tox 2008;21:1690–1697.
29. Muller J, Huaux Fo, Fonseca A, Nagy JB, Moreau N, Delos M, et al. Structural defects play a major role in the acute lung toxicity of multiwall carbon nanotubes: toxicological aspects. Chem Res Tox 2008;21:1698–1705.
30. Tian F, Cui D, Schwarz H, Estrada GG, Kobayashi H. Cytotoxicity of single-wall carbon nanotubes on human fibroblasts. Toxicol In Vitro 2006;20:1202–1212.
31. Stone V, Johnston H, Schins RP. Development of in vitro systems for nanotoxicology: methodological considerations. Crit Rev Toxicol 2009;39:613–626.
32. Donaldson K, Aitken R, Tran L, Stone V, Duffin R, Forrest G, et al. Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol Sci 2006;92:5–22.
33. Wick P, Manser P, Limbach LK, Dettlaff-Weglikowska U, Krumeich F, Roth S, et al. The degree and kind of agglomeration affect carbon nanotube cytotoxicity. Tox Letts 2007;168:121–131.
34. Thurnherr T, Su DS, Diener L, Weinberg G, Manser P, Pfaender N, et al. Comprehensive evaluation of in vitro toxicity of three large-scale produced carbon nanotubes on human Jurkat T cells and a comparison to crocidolite asbestos. Nanotox 2009;3: 319–338.
35. Clift MJ, Rothen-Rutishauser B, Brown DM, Duffin R, Donaldson K, Proudfoot L, et al. The impact of different nanoparticle surface chemistry and size on uptake and toxicity in a murine macrophage cell line. Toxicol Appl Pharm 2008;232:418–427.
36. Clift MJ, Gehr P, Rothen-Rutishauser B. In vitro testing for nanotoxicology: a valid alternative? Arch Toxicol 2011;85:723–731.
37. Clift MJ, Endes C, Vanhecke D, Wick P, Gehr P, Schins RP, et al. A comparative study of different in vitro lung cell culture systems to assess the most beneficial tool for screening the potential adverse effects of carbon nanotubes. Toxicol Sci (in Press).
38. Donaldson K, Stone V, Borm PJ, Jimenez LA, Gilmour PS, Schins RP, et al. Oxidative stress and calcium signaling in the adverse effects of environmental particles (PM10). Free Rad Biol Med 2003;34:1369–1382.
39. Brown DM, Kinloch IA, Bangert U, Windle AH, Walter DM, Walker GS, et al. An in vitro study of the potential of carbon nanotubes and nanofibres to induce inflammatory mediators and frustrated phagocytosis. Carbon 2007;45:1743–1756.
40. Donaldson K, Tran CL. Inflammation caused by particles and fibers. Inhal Toxicol 2002;14:5–27.
41. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001;104:487–501.
42. Kagan VE, Konduru NV, Feng W, Allen BL, Conroy J, Volkov Y, et al. Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation. Nat. Nanotech 2010;5:354–359.
43. Rothen-Rutishauser B, Brown DM, Piallier-Boyles M, Kinloch IA, Windle AH, Gehr P, et al. Relating the physicochemical characteristics and dispersion of multiwalled carbon nanotubes in different suspension media to their oxidative reacitivity in vitro and inflammation in vivo. Nanotox 2010;4:331–342.
44. Bussy C, Pinault M, Cambedouzou J, Landry MJ, Jegou P, Mayne-L'hermite M, et al. Critical role of surface chemical modifications induced by length shortening on multi-walled carbon nanotubes-induced toxicity. Part Fibre Toxicol 2012;9:46.
45. Thurnherr T, Brandenberger C, Fischer K, Diener L, Manser P, Maeder-Althaus X, et al. A comparison of acute and long-term effects of industrial multiwalled carbon nanotubes on human lung and immune cells in vitro. Tox Letts 2011;200:176–186.
46. Lehmann A, Brandenberger C, Blank F, Gehr P, Rothen Rutishauser B. A 3D model of the human epithelial airway barrier. In: Yarmush ML, Langer RS, editors. Alternatives to animal testing. Artech House 2010:239–260.
47. Steiner S, Muller L, Popovicheva OB, Raemy DO, Czerwinski J, Comte P, et al. Cerium dioxide nanoparticles can interfere with the associated cellular mechanistic response to diesel exhaust exposure. Tox Letts 2012;214:218–225.
48. Worle-Knirsch JM, Pulskamp K, Krug HF. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Letts 2006;6:6.
49. Wilson MR, Lightbody JH, Donaldson K, Sales J, Stone V. Interactions between ultrafine particles and transition metals in vivo and in vitro. Toxciol Appl Pharm 2002;184:172–179.
50. Foucaud L, Wilson MR, Brown DM, Stone V. Measurement of reactive species production by nanoparticles prepared in biologically relevant media. Tox Letts 2007;174:1–9.
51. Pal AK, Bello D, Budhlall B, Rogers E, Milton DK. Screening for oxidative stress elicited by engineered nanomaterials: evaluation of acellular DCFH Assay. Dose-Response 2012;10:308–330.